Hemophilia in Patients 50 Years or Older: Quality of Life, Health Maintenance, Cancer Screening and COVID19

INTRODUCTION: Major progress has been made in treatment of patients with hemophilia over the last 30 or 40 years. Factor replacement, eliminating HIV and hepatitis C transmission, and more recently, longer-acting coagulation factors and immune treatments play a role in allowing patients with hemophi...

Descripción completa

Detalles Bibliográficos
Autores principales: Katiyar, Vatsala, Day, Mackenzie, Schum, Mandy, Gaslin, Tracey, Brown, Racquel, Radulescu, Vlad Calin, Cisak, Kamila I., Munker, Reinhold
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Hematology. Published by Elsevier Inc. 2021
Materias:
322.Disorders of Coagulation or Fibrinolysis: Clinical and Epidemiological
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8701470/
http://dx.doi.org/10.1182/blood-2021-149814

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8701470/
http://dx.doi.org/10.1182/blood-2021-149814

Ejemplares similares